Connection

Laurent Peyrin-Biroulet to Certolizumab Pegol

Back to Details
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Certolizumab Pegol.
Laurent Peyrin-Biroulet
Connection Strength
0.218
Certolizumab Pegol
  1. Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience. Inflamm Bowel Dis. 2017 06; 23(6):976-985.
    View in: PubMed
    Score: 0.172
  2. Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Aliment Pharmacol Ther. 2018 10; 48(8):831-838.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.